Sequencing and functional assessment of hPXR (NR1I2) variants in intrahepatic cholestasis of pregnancy

References

• Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: Prevalence and ethnic distribution. Ethnicity and Health 1999; 4: 35–37
   PubMedGoogle Scholar
• Bosch TM, Deenen M, Pruntel R, Smits PH, Schellens JH, Beijnen JH, Meijerman I. Screening for polymorphisms in the PXR gene in a Dutch population. European Journal of Clinical Pharmacology 2006; 62: 395–399
   Google Scholar
• Castano G, Lucangioli S, Sookoian S, Mesquida M, Lemberg A, Di Scala M, Franchi P, Carducci C, Tripodi V. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clinical Science (London) 2006; 110: 459–465
   Google Scholar
• Dixon PH, Weerasekera N, Linton KJ, Donaldson O, Chambers J, Egginton E, Weaver J, Nelson-Piercy C, De Swiet M, Warnes G, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: Evidence for a defect in protein trafficking. Human Molecular Genetics 2000; 9: 1209–1217
   PubMed Web of Science ®Google Scholar
• Eloranta ML, Heinonen S, Mononen T, Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clinical Genetics 2001; 60: 42–45
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: A randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005; 42: 1399–1405
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40: 467–474
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Molecular Pharmacology 1999; 56: 1329–1339
   PubMed Web of Science ®Google Scholar
• Heinonen S, Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstetrics and Gynecology 1999; 94: 189–193
   PubMed Web of Science ®Google Scholar
• Holzbach RT, Sivak DA, Braun WE. Familial recurrent intrahepatic cholestasis of pregnancy: A genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology 1983; 85: 175–179
   Google Scholar
• Hustert E, Zibat A, Presecan-Siedel E, Eiselt R, Mueller R, Fuss C, Brehm I, Brinkmann U, Eichelbaum M, Wojnowski L, et al. Natural protein variants of pregnane X receptor with altered transactivation activity toward CYP3A4. Drug Metabolism and Disposition 2001; 29: 1454–1459
   PubMed Web of Science ®Google Scholar
• Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 210–211
   PubMed Web of Science ®Google Scholar
• King CR, Xiao M, Yu J, Minton MR, Addleman NJ, Van Booven DJ, Kwok PY, McLeod HL, Marsh S. Identification of NR1I2 genetic variation using resequencing. European Journal of Clinical Pharmacology 2007; 63: 547–554
   PubMed Web of Science ®Google Scholar
• Koyano S, Kurose K, Ozawa S, Saeki M, Nakajima Y, Hasegawa R, Komamura K, Ueno K, Kamakura S, Nakajima T, et al. Eleven novel single nucleotide polymorphisms in the NR1I2 (PXR) gene, four of which induce non-synonymous amino acid alterations. Drug Metabolism and Pharmacokinetics 2002; 17: 561–565
   PubMedGoogle Scholar
• Koyano S, Kurose K, Saito Y, Ozawa S, Hasegawa R, Komamura K, Ueno K, Kamakura S, Kitakaze M, Nakajima T, et al. Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): One variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. Drug Metabolism and Disposition 2004; 32: 149–154
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation 1998; 102: 1016–1023
   PubMed Web of Science ®Google Scholar
• Lim YP, Huang JD. Pregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1. Pharmacogenetics and Genomics 2007; 17: 369–382
   Google Scholar
• Lim YP, Liu CH, Shyu LJ, Huang JD. Functional characterization of a novel polymorphism of pregnane X receptor, Q158K, in Chinese subjects. Pharmacogenetics and Genomics 2005; 15: 337–341
   PubMed Web of Science ®Google Scholar
• Mullenbach R, Bennett A, Tetlow N, Patel N, Hamilton G, Cheng F, Chambers J, Howard R, Taylor-Robinson SD, Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 2005; 54: 829–834
   PubMed Web of Science ®Google Scholar
• Mullenbach R, Linton KJ, Wiltshire S, Weerasekera N, Chambers J, Elias E, Higgins CF, Johnston DG, McCarthy MI, Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. Journal of Medical Genetics 2003; 40: e70
   PubMed Web of Science ®Google Scholar
• Painter JN, Savander M, Ropponen A, Nupponen N, Riikonen S, Ylikorkala O, Lehesjoki AE, Aittomaki K. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. European Journal of Human Genetics 2005; 13: 435–439
   PubMed Web of Science ®Google Scholar
• Pauli-Magnus C, Lang T, Meier Y, Zodan-Marin T, Jung D, Breymann C, Zimmermann R, Kenngott S, Beuers U, Reichel C, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004; 14: 91–102
   PubMedGoogle Scholar
• Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proceedings of the National Academy of Sciences, USA, 2001. 98: 3369–3374
   Google Scholar
• Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, Shevchuk V, Moore GE, Lammert F, Glantz AG, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007; 133: 507–516
   PubMed Web of Science ®Google Scholar
• Williamson C. Drugs in pregnancy. Gastrointestinal disease. Best Practice in Research in Clinical Obstetrics and Gynaecology 2001; 15: 937–952
   PubMed Web of Science ®Google Scholar
• Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, et al. The human pregnane X receptor: Genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 2001; 11: 555–572
   PubMedGoogle Scholar